The results are what they are in Rida. I thought it would be very close, a 50/50. The results certainly weren't overwhelming (the median PFS), but, the .0001 P value says a great deal (this was not chance), and I'm sure some of the subsets are going to show tremendous efficacy.
I was on the fence about them hitting their numbers in the trial, glad, they met them. Now, that I know what they are, and they were positive, I see no reason to argue against the results. They are what they are.
It's stupid to say that Merck isn't saying anything because they aren't going to file an NDA. Ridiculous.
